Status
Conditions
Treatments
About
Objectives:
To further evaluate the immediate, long-term and cumulative effects of Tian Jiu Therapy on asthma.
Hypothesis to be tested:
The efficacy of Tian Jiu Therapy on asthma is also long-term and will be accumulated.
Design and Subjects:
Recruiting 167 asthma participants who received Tian Jiu Therapy under the primary study of HKCTR-1128. All subjects should be above age 13 and receive the same Tian Jiu Therapy, 3 times per year from 2013 to 2015. A one-year follow-up after the last Tian Jiu treatment will be conducted.
Study instruments:
Modern USB PC-based Spirometer and Fingertip Pulse Oximeter.
Interventions:
Plastering some stimulating Chinese herbal cubes on certain acupoints in the three hottest days of each year, for three consecutive years.
Main outcome measures:
Pulmonary Function Test, Blood Oxygen Test, Quality of Life and Standardized Questionnaire on asthma attack and symptoms will be administered before treatment, after treatment of each year and one-year follow-up after the last treatment.
Data analysis:
All the parameters will be analyzed, the physical improvement (Cured, Remarkably effective, Effective and Ineffective) will be recorded, and the differences in different treatment courses will be investigated and compared with previous data obtained in the primary study of HKCTR-1128 by using standard statistical analysis.
Expected results:
The effect of Tian Jiu Therapy on Asthma is not only immediate but also long-term and will be gradually accumulated.
The Tian Jiu Therapy will acquire better efficacy on asthma if this treatment was conducted more years continuously.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Diagnostic Criteria of Asthma according to U.S.DHHS(2007):
Exclusion criteria
Patients currently experiencing Acute asthma attack
Infants and child under thirteen years old 3.Pregnant women
Patients with
Fever and pharyngitis
Tuberculosis
Severe cardiac and pulmonary diseases
Diabetes Mellitus
Hypersensitive skin condition
Allergy to topical medication
Keloid
Bleeding disorders
Severe heart diseases and with pacemaker.
136 participants in 1 patient group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal